First Tracks Biotherapeutics to be spun off from AnaptysBio, Nasdaq trading set for April 20

📌 Key Takeaways

• First Tracks Biotherapeutics is being spun off from AnaptysBio as an independent company.
• The spin-off will be completed on April 20, 2024.
• First Tracks will begin trading on the Nasdaq stock exchange under the ticker symbol 'FTRK'.
• The company will focus on developing novel antibody-based therapeutics.
• The separation aims to allow each entity to pursue distinct strategic priorities.

🏷️ Themes

Corporate Spin-off, Biotechnology, Financial Markets

Entity Intersection Graph

No entity connections available yet for this article.

Source

investing.com